1887

Abstract

Protease IV is important in the pathogenesis of -induced microbial keratitis, but little is known of its role in cystic fibrosis (CF) lung infection. In this study protease IV production was examined in 43 isolates (24 non-clonal and 19 clonal) from the lungs of chronically infected adult patients attending the Royal Prince Alfred Hospital CF Clinic, Sydney, Australia. Overall, 32/43 (74 %) isolates were positive for protease IV protein by Western blotting and 22/43 (51 %) had evidence of active protease IV on gelatin zymography. Clonal strains were 1.6 times more likely than non-clonal strains to produce protease IV [18/19 (95 %) versus 14/24 (58 %), RR=1.6, CI 1.1–2.3, =0.007] and 3 times more likely to secrete the protein [16/19 (84 %) versus 6/24 (25 %), RR=3.4, CI 1.6–6.9, <0.001]. Nine of the ten strains negative by both Western blotting and zymography were non-clonal, and all but one of these was positive for the protease IV gene. There was a marked strain-to-strain variation in the amount of protease IV produced. Secretion of protease IV by clonal strains may enhance their infectivity and ability to adapt to the changing CF lung environment. Overall the findings suggest that protease IV plays an important role in the pathogenesis of infection in the CF lung.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46845-0
2006-12-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/12/1641.html?itemId=/content/journal/jmm/10.1099/jmm.0.46845-0&mimeType=html&fmt=ahah

References

  1. Anthony, M., Rose, B., Pegler, M. B. & 8 other authors ( 2002; ). Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J Clin Microbiol 40, 2772–2778.[CrossRef]
    [Google Scholar]
  2. Armstrong, D., Bell, S., Robinson, M. & 8 other authors ( 2003; ). Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 41, 2266–2267.[CrossRef]
    [Google Scholar]
  3. Caballero, A. R., Moreau, J. M., Engel, L. S., Marquart, M. E., Hill, J. M. & O'Callaghan, R. J. ( 2001; ). Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases. Anal Biochem 290, 330–337.[CrossRef]
    [Google Scholar]
  4. Caballero, A., Thibodeaux, B., Marquart, M., Traidej, M. & O'Callaghan, R. ( 2004; ). Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases. Invest Ophthalmol Vis Sci 45, 522–530.[CrossRef]
    [Google Scholar]
  5. Engel, L. S., Hobden, J. A., Moreau, J. M., Callegan, M. C., Hill, J. M. & O'Callaghan, R. J. ( 1997; ). Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest Ophthalmol Vis Sci 38, 1535–1542.
    [Google Scholar]
  6. Engel, L. S., Hill, J. M., Caballero, A. R., Green, L. C. & O'Callaghan, R. J. ( 1998a; ). Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem 273, 16792–16797.[CrossRef]
    [Google Scholar]
  7. Engel, L. S., Hill, J. M., Moreau, J. M., Green, L. C., Hobden, J. A. & O'Callaghan, R. J. ( 1998b; ). Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci 39, 662–665.
    [Google Scholar]
  8. Goodman, A. L. & Lory, S. ( 2004; ). Analysis of regulatory networks in Pseudomonas aeruginosa by genomewide transcriptional profiling. Curr Opin Microbiol 7, 39–44.[CrossRef]
    [Google Scholar]
  9. Grimwood, K., To, M., Semple, R. A., Rabin, H. R., Sokol, P. A. & Woods, D. E. ( 1993; ). Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol 15, 135–139.[CrossRef]
    [Google Scholar]
  10. Holloway, B. W., Krishnapillai, V. & Morgan, A. F. ( 1979; ). Chromosomal genetics of Pseudomonas. Microbiol Rev 43, 73–102.
    [Google Scholar]
  11. Jain, M., Ramirez, D., Seshadri, R. & 7 other authors ( 2004; ). Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol 42, 5229–5237.[CrossRef]
    [Google Scholar]
  12. Jones, A., Govan, J., Doherty, C., Dodd, M., Isalka, B., Stanbridge, T. & Webb, A. ( 2001; ). Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358, 557–558.[CrossRef]
    [Google Scholar]
  13. Malloy, J. L., Veldhuizen, R. A., Thibodeaux, B. A., O'Callaghan, R. J. & Wright, J. R. ( 2005; ). Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol 288, L409–L418.
    [Google Scholar]
  14. McCallum, S., Corkill, J., Gallagher, M., Ledson, M., Hart, C. & Walshall, M. ( 2001; ). Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 358, 558–560.[CrossRef]
    [Google Scholar]
  15. Mellins, R. B., Levine, O. R., Ingram, R. H. & Fishman, A. P. ( 1968; ). Obstructive disease of the airways in cystic fibrosis. Pediatrics 41, 560–573.
    [Google Scholar]
  16. O'Callaghan, R. J., Engel, L. S., Hobden, J. A., Callegan, M. C., Green, L. C. & Hill, J. M. ( 1996; ). Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci 37, 534–543.
    [Google Scholar]
  17. O'Carroll, M. R., Syrmis, M. W., Wainwright, C. E., Greer, R. M., Mitchell, P., Coulter, C., Sloots, T. P., Nissen, M. D. & Bell, S. C. ( 2004; ). Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 24, 101–106.[CrossRef]
    [Google Scholar]
  18. Scott, F. W. & Pitt, T. L. ( 2004; ). Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 53, 609–615.[CrossRef]
    [Google Scholar]
  19. Smith, E. E., Buckley, D. G., Wu, Z. & 10 other authors ( 2006; ). Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103, 8487–8492.[CrossRef]
    [Google Scholar]
  20. Traidej, M., Caballero, A. R., Marquart, M. E., Thibodeaux, B. A. & O'Callaghan, R. J. ( 2003; ). Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida. Invest Ophthalmol Vis Sci 44, 190–196.[CrossRef]
    [Google Scholar]
  21. Wilderman, P. J., Vasil, A. I., Johnson, Z., Wilson, M. J., Cunliffe, H. E., Lamont, I. L. & Vasil, M. L. ( 2001; ). Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa. Infect Immun 69, 5385–5394.[CrossRef]
    [Google Scholar]
  22. Zhu, H., Thuruthyil, S. J. & Willcox, M. D. ( 2002; ). Determination of quorum-sensing signal molecules and virulence factors of Pseudomonas aeruginosa isolates from contact lens-induced microbial keratitis. J Med Microbiol 51, 1063–1070.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46845-0
Loading
/content/journal/jmm/10.1099/jmm.0.46845-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error